US FDA Warning Letter Scrutinizes Abbott Over Cybersecurity, Battery Lapses
Executive Summary
FDA investigators are concerned Abbott's St. Jude Medical subsidiary failed to adequately address concerns over cybersecurity vulnerabilities and premature battery drain on their cardiac devices manufactured at its Sylmar, Calif., facility.